Clinical Trial News

Chronic Lymphocytic Leukemia (CLL) is a cancer that affects the blood and bone marrow, specifically the white blood cells called lymphocytes. CLL is a chronic leukemia, meaning it develops slowly and can progress slowly over months or years. It is one of the […]

The ECHO Research Department recently hosted Valerie Gabarre, MD (Medical Director) and Berangere Vasseu, MD (Chief Medical Officer) from the French company OSE Immunotherapeutics. OSE Immunotherapeutics is an integrated biotechnology company focused on developing and partnering therapies to control the immune system for […]

We are thrilled to announced that ECHO has enrolled the first patient in the world into a new clinical trial.  The trial is for patients with metastatic Non-Small Cell Lung Cancer (NSCLC) who have progressed while receiving maintenance immunotherapy.  The trial will compare […]

ECHO is proud to have a leading edge research team who provides patients with access to some of the most current clinical trials in the world. One of these trials is for unresectable locally advanced or metastatic colon cancer with […]

ECHO was pleased to be featured on Connecticut East This Week. Our Director of Research, Dr. Susan Johnson, shared the important role of clinical trials, while a patient shared her personal journey. Thank you to Brian Scott-Smith for allowing ECHO to share […]

Clinical trials help inform our understanding of cancer and improve prevention, diagnosis, treatment, and care.They play a significant role in the development of innovative and potentially life-saving therapies.  There are many new exciting clinical trials on the horizon. Trials may be […]